A Multicenter Non-Interventional Study Evaluating Bleeds and Health-Related Quality Of Life in Patients With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

Summary

This non-interventional study (NIS) is designed to collect information on the effectiveness and safety of treatment received in routine clinical care, as well as measure the health-related quality of life (HRQoL) of participants with Type 3 von Willebrand disease (VWD) receiving prophylactic therapy per local standard of care (SOC) over an observation period of at least 24 weeks.

Eligibility

Age range

2+ years

Sex

All

Healthy volunteers

No

Interventions

• Drug
  Von Willebrand Factor Concentrates

  Used according to local labeling or local treatment guidelines.

• Drug
  Von Willebrand Factor Concentrates and Factor VIII Concentrates

  Used according to local labeling or local treatment guidelines.

• Drug
  Factor VIII Concentrates

  Used according to local labeling or local treatment guidelines.

• Drug
  Recombinant Activated Factor VII

  Used according to local labeling or local treatment guidelines.

• Drug
  Activated Prothrombin Complex Concentrate

  Used according to local labeling or local treatment guidelines.

Locations (27)